Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Licenses Biopendium Database to Fifth Japanese Customer

NEW YORK, Nov. 30 (GenomeWeb News) - Inpharmatica has sold an online subscription to its Biopendium protein-annotation database to Shionogi of Japan, the company said today.

 

The subscription, the fifth to a Japanese customer, was sold through PharmaDesign, Inpharmatica's sales and marketing partner in Japan.

 

Biopendium, the protein annotation component of Inpharmatica's PharmaCarta platform, provides sequence annotation for over 150 organisms. The company recently added a microarray analysis module.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.